Phase II
Showing 9976 - 10000 of >10,000
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Advanced Malignant Tumor Trial (SHR-5495 for injection)
Not yet recruiting
- Advanced Malignant Tumor
- SHR-5495 for injection
- (no location specified)
Sep 26, 2023
Iron Deficiency Anemia (IDA) Trial in Poland, Russian Federation (Ferric Carboxymaltose (FCM))
Completed
- Iron Deficiency Anemia (IDA)
- Ferric Carboxymaltose (FCM)
-
Bydgoszcz, Poland
- +9 more
Jul 21, 2022
Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor Trial in United States (biological,
Active, not recruiting
- Ovarian Granulosa Cell Tumor
- +6 more
- Bleomycin Sulfate
- +5 more
-
Anchorage, Alaska
- +218 more
Dec 30, 2021
HER-2 Positive Breast Cancer Trial in Italy (Liposomal doxorubicin, Docetaxel, Trastuzumab)
Completed
- HER-2 Positive Breast Cancer
- Liposomal doxorubicin
- +3 more
-
Meldola, FC, Italy
- +8 more
Apr 20, 2020
Acute Ischemic Stroke Trial in Bordeau (Intravenous glenzocimab (ACT017) 1000 mg, Intravenous Placebo)
Recruiting
- Acute Ischemic Stroke
- Intravenous glenzocimab (ACT017) 1000 mg
- Intravenous Placebo
-
Houston, Texas
- +1 more
Sep 28, 2022
Gastric Cancer Trial in Zhejiang (Sintilimab, Oxaliplatin, Capecitabine)
Unknown status
- Gastric Cancer
- Sintilimab
- +2 more
-
Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang University
Feb 7, 2020
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Nasopharyngeal Carcinoma Trial in Shanghai (Carbon ion radiotherapy (CIRT))
Terminated
- Nasopharyngeal Carcinoma
- Carbon ion radiotherapy (CIRT)
-
Shanghai, Shanghai, ChinaShanghai Proton and Heavy Ion Center
Feb 12, 2020
Melanoma Trial in Houston (Immunotherapy, Quality-of-Life Assessment, Radiation Therapy)
Recruiting
- Melanoma
- Immunotherapy
- +2 more
-
Camden, New Jersey
- +1 more
Nov 11, 2022
Progeria, Hutchinson-Gilford Syndrome Trial in Boston (Lonafarnib)
Completed
- Progeria
- Hutchinson-Gilford Syndrome
-
Boston, MassachusettsChildren's Hospital Boston
Jun 11, 2019
Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)
Completed
- Primary Myelofibrosis
- +9 more
-
Camperdown, New South Wales, Australia
- +17 more
Apr 3, 2020
Metastatic Colorectal Cancer Trial in Chuo Ku (Bevacizumab, 5-fluorouracil, Leucovorin calcium)
Recruiting
- Metastatic Colorectal Cancer
- Bevacizumab
- +5 more
-
Chuo Ku, Tokyo, JapanAc Medical Inc.
Oct 29, 2019
Cerebral Hypoxia Trial in United States (Intervention for cerebral hypoxia)
Recruiting
- Cerebral Hypoxia
- Intervention for cerebral hypoxia
-
Loma Linda, California
- +4 more
May 6, 2022
Carcinoma In Situ, Current Smoker, Malignant Tumor Trial in United States (Behavioral, Psychological or Informational
Active, not recruiting
- Carcinoma In Situ
- +4 more
- Behavioral, Psychological or Informational Intervention
- +4 more
-
Anchorage, Alaska
- +41 more
Jan 12, 2023
Metastatic Colorectal Cancer Trial in Bangkok (biological, procedure, other)
Withdrawn
- Metastatic Colorectal Cancer
- AlloStim®
- +2 more
-
Bangkok, ThailandNational Cancer Institute of Thailand
Jan 17, 2020
NSCLC, Squamous Cell Carcinoma Trial in Tianjin (CIK cell, Gemcitabine Injection, Cisplatin injection)
Completed
- Non-small Cell Lung Cancer
- Squamous Cell Carcinoma
- CIK cell
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Oct 31, 2019
Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE Trial in Houston (Atorvastatin, Pentoxifylline,
Completed
- Male Erectile Disorder
- +3 more
- Atorvastatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Relapsed Small Cell Lung Cancer Trial in Worldwide (Irinotecan, Lurbinectedin, Topotecan)
Recruiting
- Relapsed Small Cell Lung Cancer
- Irinotecan
- +2 more
-
Joliet, Illinois
- +94 more
Aug 12, 2022
Septic Shock, Vasodilatory Shock Trial in Albuquerque (Angiotensin II)
Recruiting
- Septic Shock
- Vasodilatory Shock
- Angiotensin II
-
Albuquerque, New MexicoUniversity of New Mexico Health Sciences Center
Apr 19, 2023
Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)
Active, not recruiting
- Prostate Cancer
- abiraterone acetate
- Prednisone
-
Jonesboro, Arkansas
- +204 more
Nov 30, 2022